| abstract |
The present invention comprises (a) the step of measuring ganglioside GM3 in a blood sample derived from a subject, the group consisting of visceral fat obesity, hyperglycemia, dyslipidemia, hypertension, and atherosclerosis A method for detecting at least one disease selected from or a disease in which two or more are combined, or a risk of developing the disease, The ganglioside GM3 relates to a detection method characterized by having a structure represented by the following formula (1). [Chemical 1] [In Formula (1), R 1 represents a sugar chain constituting ganglioside GM3, and R 2 —C (═O) — may have a double bond having an OH group as a substituent. A fatty acid residue having 16 to 24 carbon atoms is shown. ] |